ATE303597T1 - Hcv mosaik antigen zusammensetzung - Google Patents

Hcv mosaik antigen zusammensetzung

Info

Publication number
ATE303597T1
ATE303597T1 AT01951273T AT01951273T ATE303597T1 AT E303597 T1 ATE303597 T1 AT E303597T1 AT 01951273 T AT01951273 T AT 01951273T AT 01951273 T AT01951273 T AT 01951273T AT E303597 T1 ATE303597 T1 AT E303597T1
Authority
AT
Austria
Prior art keywords
hcv
antigen composition
mosaic antigen
diagnostic
antibodies
Prior art date
Application number
AT01951273T
Other languages
English (en)
Inventor
Hermes K W Chan
Richard Theolis Jr
Original Assignee
Medmira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medmira Inc filed Critical Medmira Inc
Application granted granted Critical
Publication of ATE303597T1 publication Critical patent/ATE303597T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01951273T 2000-07-07 2001-07-06 Hcv mosaik antigen zusammensetzung ATE303597T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2311022 2000-07-07
PCT/CA2001/000988 WO2002004484A2 (en) 2000-07-07 2001-07-06 Hcv mosaic antigen composition

Publications (1)

Publication Number Publication Date
ATE303597T1 true ATE303597T1 (de) 2005-09-15

Family

ID=4166420

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01951273T ATE303597T1 (de) 2000-07-07 2001-07-06 Hcv mosaik antigen zusammensetzung

Country Status (6)

Country Link
EP (1) EP1328811B1 (de)
AT (1) ATE303597T1 (de)
AU (1) AU2001272257A1 (de)
DE (1) DE60113139T2 (de)
ES (1) ES2248357T3 (de)
WO (1) WO2002004484A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1357127A1 (de) * 2002-04-10 2003-10-29 Immusystems GmbH CD4+ T-Lymphozyten spezifische Hepatitis C Virus-Epitope
US20040106526A1 (en) * 2002-12-03 2004-06-03 Baxter David Roderick Method for marking liquid hydrocarbons
KR20060087574A (ko) * 2003-09-22 2006-08-02 가부시키가이샤 그린 펩티드 Ｃ형 간염 바이러스 유래 펩티드
US8475735B2 (en) 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
JP2009511024A (ja) * 2005-10-13 2009-03-19 ヴィレックス メディカル コーポレイション 免疫応答を誘導するためのＣ型肝炎ウイルスポリペプチドおよびＦｃフラグメントを含むキメラ抗原
JP2009018990A (ja) * 2005-10-25 2009-01-29 Univ Kurume Ｃ型肝炎ウイルス由来ペプチド
CA2629290C (en) * 2005-11-12 2014-05-06 Carolyn Jennifer Ruddell Agglutination assay
CA2580589C (en) 2006-12-19 2016-08-09 Fio Corporation Microfluidic detection system
JP4975601B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
JP4975600B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
EP1978365B1 (de) 2007-03-16 2010-08-25 Sysmex Corporation Reagenzkit und Verfahren zur Messung von HCV-Antikörpern
CN101861203B (zh) 2007-10-12 2014-01-22 Fio公司 用于形成浓缩体积的微珠的流动聚焦方法和系统以及形成的微珠
US9792809B2 (en) 2008-06-25 2017-10-17 Fio Corporation Bio-threat alert system
BRPI0917839A2 (pt) 2008-08-29 2015-11-24 Fio Corp dispositivo de teste de diagnóstico portátil de uso único, e um sistema associado e método para teste de amostras de teste ambientais e biológicas
CN104374932A (zh) 2009-01-13 2015-02-25 Fio公司 与电子设备和快速诊断测试中的测试盒结合使用的手持诊断测试设备
EP3715374A1 (de) 2019-03-23 2020-09-30 Ablevia biotech GmbH Verbindung zur sequestrierung von unerwünschten antikörpern in einem patienten
US11986536B2 (en) 2019-03-23 2024-05-21 Ablevia Biotech Gmbh Compound for the sequestration of undesirable antibodies in a patient
CN118818064A (zh) * 2024-08-23 2024-10-22 深圳上泰生物工程有限公司 一种抗磷脂酶a2受体抗体检测试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2161682T3 (es) * 1990-11-03 2001-12-16 Dade Behring Marburg Gmbh Peptidos especificos a hcv, agentes adecuados para ellos y su utilizacion.
ATE144993T1 (de) * 1990-12-14 1996-11-15 Innogenetics Nv Synthetische antigene zum nachweis von antikörpern gegen hepatitis c-virus
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)

Also Published As

Publication number Publication date
AU2001272257A1 (en) 2002-01-21
DE60113139T2 (de) 2006-06-22
WO2002004484A3 (en) 2002-03-28
ES2248357T3 (es) 2006-03-16
WO2002004484A2 (en) 2002-01-17
DE60113139D1 (de) 2005-10-06
EP1328811A2 (de) 2003-07-23
EP1328811B1 (de) 2005-08-31

Similar Documents

Publication Publication Date Title
DE60113139D1 (de) Hcv mosaik antigen zusammensetzung
US7402315B2 (en) Hepatitis-C virus type 4, 5 and 6
CN1360678B (zh) 借助ns1糖蛋白对黄病毒进行早期检测的方法及其应用
RU2001101869A (ru) Частицы белков оболочки HCV: применение для вакцинации
EP0698216B2 (de) Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien
BRPI0111682B8 (pt) suporte sólido de imunoensaio, kit de teste de imunodiagnóstico, métodos de produção de um suporte sólido de imunoensaio, e de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e, uso de um suporte sólido de imunoensaio
KR970010925B1 (ko) Hcv 펩티드-항원 및 c형 간염 바이러스(hcv)의 검사 방법
KR20010042807A (ko) 환원제를 사용하는 개선된 면역진단 분석법
EP1504266A2 (de) Verfahren zum gleichzeitigen nachweis eines antigens und eines antikörpers eines infektiösen mikroorganismus
EP1806363A4 (de) Verfahren zum nachweis vonhepatitis-b-virus-s-antigen
EP1878797A3 (de) Antigene Peptide zur Gruppierung des Hepatitis-C-Virus, Kit damit und Verfahren zur Gruppierung unter Verwendung dieses Kits
ATE115964T1 (de) Non-a non-b sequenzen.
RU2008120331A (ru) Маркированные вирусные вакцины против бычьей вирусной диареи
ZHANG et al. Hepatitis C virus antibodies and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction
JP3199995B2 (ja) Ｃ型肝炎の感染の診断および検出に効果的なペプチド
US5885771A (en) Antigenic peptide compound and immunoassay
IE922548A1 (en) Non-a, non-b peptide
KR19990044211A (ko) 항원 펩타이드 화합물 및 면역학적 측정 방법
CA2151126A1 (en) Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv
CA2151128A1 (en) Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same
EP0829488A1 (de) Antigene peptidsubstanz und immotestverfahren
TH54286A (th) สายพันธุ์ไคเมอริค IBDV ซีโรไทพ์ (serotype chimeric IBDV strains)
Birkett Expression, Purification and Characterization of Hepatitis C Virus Core Protein from E. Coli Using a Chemically Synthesized Gene (1), and Cloning, Expression, Purification and Characterization of the Major Core Protein (P26) from Equine Infectious Anaemia Virus
JPH07179493A (ja) 抗原ペプチド化合物および免疫学的測定方法

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties